Wegovy Side Effects: Black Tongue, Gallbladder
Analysis based on 7 articles · First reported Apr 13, 2026 · Last updated Apr 14, 2026
The event could negatively impact the stock price and reputation of Novo Nordisk, the manufacturer of Semaglutide, as public awareness of potential severe side effects increases. It may also lead to increased scrutiny and potentially stricter regulations on weight-loss injections, affecting the broader pharmaceutical and healthcare industries.
Sarah-Jayne Crawford, 32, began taking Semaglutide in August 2024 for weight loss. After increasing her dosage, she experienced severe side effects including sharp stomach pains, frequent vomiting, and her tongue turning jet black. Scans at Antrim Area Hospital revealed multiple gallstones blocking her bile duct and diverticulitis, leading her to stop the injections. In February 2025, she underwent a cholecystectomy to remove her gallbladder. Sarah-Jayne Crawford is now raising awareness about the potential dangers of weight-loss injections. Novo Nordisk, the manufacturer of Semaglutide, acknowledged that gallstones are a common potential adverse reaction listed in the product's Summary of Product Characteristics.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard